Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Weighted Average Inputs and Assumptions

	2023			2022
Grant date stock price and exercise price	$	12.03		$	15.80
Dividend yield		2.89	%		2.48	%
Expected stock price volatility		23.37	%		23.59	%
Risk-free interest rate		3.50	%		2.17	%
Expected option life in years		6			6
Total weighted-average fair value of options granted	$	2.42		$	3.00

Schedule of Stock Options Activity

A summary of stock option activity in 2023 is presented below (Aggregate Intrinsic Value in thousands):

	Shares Subject to Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding at beginning of year		144,020		$	14.07		2.8 years		95
Granted		10,250			12.03		6.3 years		—
Exercised		—			—		—		—
Forfeited or expired		(16,770	)		14.53		2.1 years		—
Outstanding at end of year		137,500		$	13.86		2.1 years	$	—
Exercisable at year-end		109,700		$	14.23		1.4 years	$	—

Schedule of Information related to Stock Option Exercise

Information related to stock option exercises during each year is as follows (dollars in thousands):

	2023		2022
Intrinsic value of options exercised	$	—	$	17
Cash received from options exercised	$	—	$	—
Tax benefit realized from options exercised	$	—	$	15

Schedule of Non-Vested Restricted Stock Activity

A summary of restricted stock activity for the year ended December 31, 2023, is presented below:

	Shares			Weighted- Average Grant Date Fair Value		Average Remaining Contractual Term
Non-vested on January 1, 2023		6,500		$	14.89		4.1 years
Granted		10,250			12.03		4.3 years
Vested		(1,300	)		14.89		3.2 years
Forfeited		(2,050	)		13.18		3.8 years
Non-vested on December 31, 2023		13,400		$	12.97		3.9 years

Schedule of Unrecognized Equity-Based Expense under 2017 Equity Incentive Plan

Year
2024	$	64
2025		61
2026		49
2027		29
2028		7
Totals	$	210